
Cancer of unknown primary site zzso is a well zzso clinical disorder, accounting for zzso of all zzso zzso zzso zzso is clinically zzso as an aggressive disease with early zzso zzso approaches to identify the primary site include detailed zzso examination with specific zzso and zzso zzso zzso zzso diagnosis has high sensitivity, but further prospective study is necessary to establish whether patients' outcomes are improved by its clinical zzso zzso zzso is the most common zzso zzso zzso zzso patients are divided into zzso of zzso zzso and zzso zzso zzso zzso zzso are mostly given zzso treatment or systemic zzso zzso zzso and survival are similar to those of patients with relevant known primary zzso Patients in zzso zzso are treated with empirical chemotherapy based on combination regimens of platinum or zzso but responses and survival are generally zzso 

